SPEAKERS:
• Prof. Dr. Lídia Moreira Lima
Full Professor of the Biomedical Sciences Institute at Universidade Federal do Rio de Janeiro (UFRJ). She works in the Laboratory of Evaluation and Synthesis of Bioactive Substances (LASSBio, ICB, UFRJ) in research projects in the field of Medicinal Chemistry, working with the following subjects: design and synthesis of new anti-inflammatory drugs; new oral chemotherapeutic and hypoglycemic drug candidates; optimization of lead compounds; study of drug-likeness properties and metabolism of xenobiotics.

• Prof. Dr. Fabrício Figueiró
Doctor in Biochemistry by the Federal University of Rio Grande do Sul (2015) with one year abroad at Pittsburgh University-USA. Post-doctor in Biochemistry also by UFRGS (2015-2017). He works with the investigation of drugs and drug candidates, carried by nanoparticles or not, for the control of tumor progression. Currently is a professor at the Department of Biochemistry and at the Biochemistry Graduate Program of UFRGS (2017-present), where he coordinates the Laboratory of Cancer Immunobiochemistry (LIBC).

• Prof. Dr. Elizandra Braganhol
Currently she works as a professor/researcher at UFCSPA, Coordinator of Graduate/Prorector of Research and Adjunct Graduate Studies. She has experience in the field of cell biochemistry and immunology, with emphasis on the study of the purinergic system, the role of ectonucleotidases and purinergic receptors in physiopathological conditions. The main subjects of her scientific research include: the purinergic system in human sepsis; study of tumor microenvironment and cancer inflammatory process; the development of new antitumor drugs based in nanotechnology with focus on inflammation-related cancer intervention.

• Prof. Dr. Fernanda Bueno Morrone
Full Professor at the School of Health Sciences, PUCRS, where she teaches Pharmacology and Clinical Pharmacy. She is a member of the Brazilian Society of Therapeutic and Experimental Pharmacology and a member of the Brazilian Purine Club. She is a consultant and reviewer for national and international scientific journals and acts as a consultant for several institutions. She has experience in Pharmacology, with special interest in the study of the purinergic system, ATP, purinergic receptors (P1R, P2R, P2X7R, P2YR) and radiotherapy in gliomas, urinary tract tumors, esophageal and breast cancer.

• Prof. Dr. Ana Maria Oliveira Battastini
Retired Full Professor of Federal University of Rio Grande do Sul (UFRGS) and acted as permanent professor of the Biochemistry Graduate Program. She has experience in the field of Biochemistry, with emphasis on the extracellular metabolism of nucleotides (Purinergic Signaling), working mainly on the following subjects: E-NTPDases, ecto-5-nucleotidases; investigation of the participation of these enzymes in central nervous system cancer (gliomas). She also researched the purinergic signaling in bladder cancer studying possible ecto-nucleotidases inhibitors, especially of ecto-5’-nucleotidase, as potential chemotherapeutic agents.

• Prof. Dr. Daiana Silva de Ávila
Completed her post-doctorate at Vanderbilt University (USA) between 2009 and 2011. She has experience in the field of Toxicological Biochemistry, with emphasis on toxicology and pharmacology of organochalcogens and toxicology of metals, pesticides and nanomaterials, besides having experience with the use of Caenorhabditis elegans as an experimental model in the field. She works as an associate professor at UNIPAMPA- Uruguaiana Campus, supervising students at the Biochemistry Graduate Program (UNIPAMPA) and Toxicological Biochemistry (UFSM). In 2015, received the Women in Science Prize- L’Oreal/UNESCO/Brazilian Sciences Academy.

• Prof. Dr. Pablo Machado
Doctor in Organic Chemistry from the Federal University of Santa Maria (2010). Completed his post-doctorate at National Institute of Science and Technology in Tuberculosis (INCT-TB). He is currently professor at the School of Health and Life Sciences at PUCRS and researcher at INCT-TB . Professor at the Graduate Program in Cellular and Molecular Biology and at the Graduate Program in Medicine and Health Sciences in the same institution. One of the coordinators of the Drug Research and Development Area of the Brazilian Tuberculosis Research Network (REDE-TB). He has experience in organic chemistry with emphasis on designing and synthesis of bioactive compounds, heterocyclic compounds, green chemistry SAR/QSAR, tuberculosis and cancer.

• Prof. Dr. Thiago Claudino
Doctor in Chemistry from the Federal University of Rio Grande do Sul (2018). He is currently a substitute professor at the Federal University of Rio Grande do Sul. He has experience in Medicinal Pharmaceutical Chemistry, participated mainly in the planning, synthesis and production of drugs.

• Prof. Dr. Fávero Reisdorfer Paula
He has experience in the field of Pharmacy, with emphasis in Medicinal and Pharmaceutical Chemistry, working in the following subjects: planning and development of bioactive compounds and drugs with application of in silico methodologies (molecular modeling, QSAR/SAR, pharmacophore, molecular docking, physico-chemical properties studies, comparative structural similarity and homology of proteins, toxicity prediction); drug synthesis and bioisosteres; and organic analysis.

• Prof. Dr. Raquel Bridi
Master in Pharmaceutical Sciences and Doctor in Biochemistry by Federal University of Rio Grande do Sul. Currently she works as a professor in the Faculty of Chemistry and Pharmacy at the Pontificia Universidad Católica de Chile, teaching the Botanic and Pharmacognosy class. Works in the field of pharmacognosy, mainly in the subjects of: oxidative stress; antioxidants; hepatoprotective activity of extracts; phenolic composition and activity of Chilean medicinal flora and honey.

• Prof. Dr. Itamar Luis Gonçalves
Master and Doctor in Pharmaceutical Sciences by the Federal University of Rio Grande do Sul. He has acted as reviewer of scientific articles for 27 international journals in fields related to Pharmaceutical Sciences and Chemistry. He works with heterocycle synthesis with potential pharmacological activity on the cell proliferation and applications in liquid crystals. He works with investigations related to the use of planarians (Giardia tigrina) as an alternative animal model in pharmacological and toxicological assays related with chemical and pharmacological properties of yerba mate extracts.